Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Williams

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Cancer Investigation|January 1, 1988
The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomasS F Williams, R L Schilsky, J E Ultmann, et al.
Cytotherapy|September 15, 2009
The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis productK L Hollingsworth, T M Zimmerman, T Karrison, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapyW J Lee, T Zimmerman, S Meyers, et al.
Breast Cancer Research and Treatment|December 1, 1993
Mitoxantrone, vincristine, and 5-fluorouracil with leucovorin modulation as induction chemotherapy prior to high-dose intensification in metastatic breast cancerS F Williams, S E Myers, S Huffman, et al.
Bone Marrow Transplantation|March 1, 1995
Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvestsT M Zimmerman, W J Lee, J G Bender, et al.
Bone Marrow Transplantation|March 7, 1998
High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experienceG F Laport, G Grad, D L Grinblatt, et al.
Journal of Clinical Apheresis|June 4, 1999
Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphomaT M Zimmerman, G C Michelson, R Mick, et al.
Journal of Neural Transmission|January 1, 1982
Presynaptic modulation of dopamine-induced locomotor activity of oxotremorine in nucleus accumbens of the ratJ S de Belleroche, P Winn, E Murzi, et al.
Progress in Clinical and Biological Research|January 1, 1994
CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapyT M Zimmerman, W J Lee, J G Bender, et al.
Journal of the National Cancer Institute|January 3, 1990
High-dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignanciesJ A Moormeier, S F Williams, L S Kaminer, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Cancer Investigation|January 1, 1988
The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomasS F Williams, R L Schilsky, J E Ultmann, et al.
Cytotherapy|September 15, 2009
The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis productK L Hollingsworth, T M Zimmerman, T Karrison, et al.
Progress in Clinical and Biological Research|January 1, 1994
Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapyW J Lee, T Zimmerman, S Meyers, et al.
Breast Cancer Research and Treatment|December 1, 1993
Mitoxantrone, vincristine, and 5-fluorouracil with leucovorin modulation as induction chemotherapy prior to high-dose intensification in metastatic breast cancerS F Williams, S E Myers, S Huffman, et al.
Bone Marrow Transplantation|March 1, 1995
Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvestsT M Zimmerman, W J Lee, J G Bender, et al.
Bone Marrow Transplantation|March 7, 1998
High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experienceG F Laport, G Grad, D L Grinblatt, et al.
Journal of Clinical Apheresis|June 4, 1999
Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphomaT M Zimmerman, G C Michelson, R Mick, et al.
Journal of Neural Transmission|January 1, 1982
Presynaptic modulation of dopamine-induced locomotor activity of oxotremorine in nucleus accumbens of the ratJ S de Belleroche, P Winn, E Murzi, et al.
Progress in Clinical and Biological Research|January 1, 1994
CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapyT M Zimmerman, W J Lee, J G Bender, et al.
Journal of the National Cancer Institute|January 3, 1990
High-dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignanciesJ A Moormeier, S F Williams, L S Kaminer, et al.
Pageof 10